These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 27039875)

  • 1. Vaccinology in the third millennium: scientific and social challenges.
    Poland GA; Whitaker JA; Poland CM; Ovsyannikova IG; Kennedy RB
    Curr Opin Virol; 2016 Apr; 17():116-125. PubMed ID: 27039875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine.
    Pregelj L; Hine DC; Oyola-Lozada MG; Munro TP
    Trends Biotechnol; 2020 Sep; 38(9):943-947. PubMed ID: 32600777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles, mumps, rubella prevention: how can we do better?
    Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
    Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Emerging infectious agents].
    Chidiac C; Ferry T
    Transfus Clin Biol; 2016 Nov; 23(4):253-262. PubMed ID: 27644171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Planning for the unexpected: Ebola virus, Zika virus, what's next?
    Welfare W; Wright E
    Br J Hosp Med (Lond); 2016 Dec; 77(12):704-707. PubMed ID: 27937012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebola and Zika: Cautionary tales.
    Osterholm MT
    Science; 2016 Sep; 353(6304):1073. PubMed ID: 27609862
    [No Abstract]   [Full Text] [Related]  

  • 7. AIDS, Avian flu, SARS, MERS, Ebola, Zika… what next?
    Reperant LA; Osterhaus ADME
    Vaccine; 2017 Aug; 35(35 Pt A):4470-4474. PubMed ID: 28633891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine development for emerging virulent infectious diseases.
    Maslow JN
    Vaccine; 2017 Oct; 35(41):5437-5443. PubMed ID: 28216184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response.
    Krubiner CB; Faden RR; Karron RA; Little MO; Lyerly AD; Abramson JS; Beigi RH; Cravioto AR; Durbin AP; Gellin BG; Gupta SB; Kaslow DC; Kochhar S; Luna F; Saenz C; Sheffield JS; Tindana PO;
    Vaccine; 2021 Jan; 39(1):85-120. PubMed ID: 31060949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectre of Ebola haunts Zika response.
    Check Hayden E
    Nature; 2016 Mar; 531(7592):19. PubMed ID: 26935676
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccine epidemiology: Its role in promoting sound immunization programs in Japan.
    Hirota Y; Ozasa K; Nakano T
    Vaccine; 2017 Aug; 35(36):4787-4790. PubMed ID: 28818469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparing for Emerging Infectious Diseases in the Perinatal Population.
    O'Rourke K; Murphy T; Srinivas SK; Pegues DA
    J Obstet Gynecol Neonatal Nurs; 2018 Mar; 47(2):245-253. PubMed ID: 28736265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain.
    Poland GA; Fleming DM; Treanor JJ; Maraskovsky E; Luke TC; Ball EM; Poland CM
    Vaccine; 2013 Apr; 31 Suppl 1():A1-20. PubMed ID: 23587330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial.
    Koren MA; Lin L; Eckels KH; De La Barrera R; Dussupt V; Donofrio G; Sondergaard EL; Mills KT; Robb ML; Lee C; Adedeji O; Keiser PB; Curley JM; Copeland NK; Crowell TA; Hutter JN; Hamer MJ; Valencia-Ruiz A; Darden J; Peel S; Amare MF; Mebrahtu T; Costanzo M; Krebs SJ; Gromowski GD; Jarman RG; Thomas SJ; Michael NL; Modjarrad K
    Lancet Infect Dis; 2023 Oct; 23(10):1175-1185. PubMed ID: 37390836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile: Gary Kobinger - "My goal became to prevent death".
    Morin V
    CMAJ; 2016 May; 188(8):561-562. PubMed ID: 27091802
    [No Abstract]   [Full Text] [Related]  

  • 16. Stopping Zika, other emerging health threats requires stronger disease surveillance systems.
    Ross D
    Mod Healthc; 2016 Oct; 46(35):25. PubMed ID: 30452800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid response to an emerging infectious disease - Lessons learned from development of a synthetic DNA vaccine targeting Zika virus.
    Kudchodkar SB; Choi H; Reuschel EL; Esquivel R; Jin-Ah Kwon J; Jeong M; Maslow JN; Reed CC; White S; Kim JJ; Kobinger GP; Tebas P; Weiner DB; Muthumani K
    Microbes Infect; 2018 Dec; 20(11-12):676-684. PubMed ID: 29555345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus.
    Maslow JN
    Hum Vaccin Immunother; 2017 Dec; 13(12):2918-2930. PubMed ID: 28846484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebola, Dengue, Chikungunya, and Zika Infections in Neonates and Infants.
    de St Maurice A; Ervin E; Chu A
    Clin Perinatol; 2021 Jun; 48(2):311-329. PubMed ID: 34030816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1555-1576. PubMed ID: 33297613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.